( OTC-PINK:QBIO, OTC-QB:QBIO, OTC-QX:QBIO, OtherOTC:QBIO )

News from Q BioMed Inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

25 Apr, 2017, 07:00 ET Q Biomed Announces Licensing Agreement for Development of Drug to Treat Rare Pediatric Disorder

Q BioMed Inc. (OTCQB: QBIO) and ASDERA LLC today announce a licensing agreement that provides Q Biomed with the worldwide exclusive rights to...


07 Feb, 2017, 08:00 ET Q Biomed Joins with Oklahoma Medical Research Foundation and Rajiv Gandhi Centre for Biotechnology to Develop Liver Cancer Chemotherapeutic

Q BioMed, Inc. (OTCQB: QBIO) has entered into an agreement with the Oklahoma Medical Research Foundation (OMRF) and the Rajiv Gandhi Centre for...


02 Feb, 2017, 08:00 ET Q BioMed Inc. Announces Mannin Research Accepted Into Johnson & Johnson Innovation, JLABS @ Toronto

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to announce that Mannin Research, its research partner for the...


05 Jan, 2017, 09:09 ET Q BioMed Inc. to Present at Biotech Showcase 2017 in San Francisco Jan 9 - 11th

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration and development company will present at the 9th Annual Biotech Showcase™ 2017 being...


30 Nov, 2016, 08:30 ET Q BioMed Inc. Announces Entry Into Definitive Funding Agreement for up to $4,000,000

Q BioMed Inc. (OTCQB: QBIO), is pleased to announce that it has entered into a definitive agreement with Yorkville Advisors Global ("Yorkville")...


19 Oct, 2016, 15:04 ET Q BioMed Inc. Technology Partner Mannin Research Inc. to Participate in a Webcast on Innovating for Ophthalmic Diseases

Q BioMed Inc. (OTCQB: QBIO), technology partner Mannin Research Inc. will present in a webcast on Innovating for Ophthalmic Diseases on October...


18 Oct, 2016, 09:29 ET Q BioMed Drug Development Partner to Attend EANM 2016 in Barcelona, Spain October 15-19 2016

Q BioMed Inc. (OTCQB: QBIO), Strontium Chloride 89 (SR89) drug development partner will attend the European Association of Nuclear Medicine (EANM)...


13 Oct, 2016, 09:03 ET Q BioMed Partner Mannin Research Executives Attending OIS@AAO 2016 & AAO

Q BioMed Inc. (OTCQB: QBIO), technology partner Mannin Research Inc will participate at the Ophthalmology Innovation Summit and the American...


07 Oct, 2016, 09:18 ET Q Biomed Comments on its Glaucoma Drug and Industry News in the Ophthalmology Space

Media Alert: CEO Interviewed on Wall St Analyst Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company with a glaucoma drug in...


07 Sep, 2016, 16:15 ET Q BioMed Closes Licensing Agreement for FDA Approved Drug

Cancer palliation drug expected to start generating revenue in less than 12 months   Q BioMed Inc. (OTCQB: QBIO), a biotechnology...


14 Jul, 2016, 08:30 ET Q BioMed Inc. Advisor and Mannin Research Inc CSO Dr Susan Quaggin Elequently Discusses Glaucoma and Man-01 with Eye on Vision Radio

Q BioMed Inc. (OTCQB: QBIO), partner Mannin Research Inc. CSO Dr. Susan Quaggin discusses glaucoma, treatment options, and her novel findings on...


01 Jun, 2016, 08:30 ET Q BioMed Inc. Reports on Current and New Potential Assets

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to report on new potential asset license/acquisition and an update on...


02 May, 2016, 09:15 ET Mannin Research to Participate at ARVO 2016 Meeting

Q BioMed Inc. (QBIO), a biotechnology acceleration company announces that its technology partner Mannin Research Inc. will be attending the...


28 Apr, 2016, 09:51 ET Media Alert - Q BioMed Inc CEO Pens Management Piece Featured in Life Science Leader

Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company reports the Company's CEO  was featured in an article he wrote on venture...


26 Apr, 2016, 08:30 ET Q BioMed Inc. to Present at the Global Chinese Financial Forum on April 30, 2016

Toronto, ON Conference Expects to Attract Over 200 Participants.  Q BioMed Inc. (OTCQB: QBIO) a biotechnology acceleration company, today...


17 Mar, 2016, 08:00 ET Q BioMed Inc. Congratulates Mannin Research on Selection to the Chicago-Canada Mentorship Program (C2MP) and Inaugural Meeting

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to congratulate Mannin Research on its selection to the C2MP program...


29 Feb, 2016, 09:45 ET Q BioMed Inc. CEO Provides Corporate Overview in an Interview With Scrip Intelligence

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to share the recently published video interview from the Biotech...


04 Feb, 2016, 08:00 ET Q BioMed Inc. Provides a Corporate Update

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to provide the following update on recent corporate...


05 Jan, 2016, 08:23 ET Q BioMed Inc. to Present at Biotech Showcase(™) 2016

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company announced today that Denis Corin, Chief Executive Officer, will present at the...


16 Dec, 2015, 09:46 ET Q BioMed Inc. Appoints Industry Executive to Management Team

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to welcome David Laskow-Pooley to the Q Team as VP Scientific &...


13 Nov, 2015, 08:30 ET Q BioMed Inc. Uplisted to OTCQB Market

Q BioMed Inc. (OTCQB: QBIO), today announced that its common stock is being uplisted to the OTCQB effective November 13, 2015. The OTCQB®...


12 Nov, 2015, 12:14 ET Q BioMed Inc. Strengthens Advisory Board

Q BioMed Inc. (OTC Pink: QBIO), a biotechnology acceleration company, is pleased to announce the addition of Mannin Research Inc. executives, Dr....


30 Oct, 2015, 08:30 ET Q BioMed Inc. and Mannin Research Inc Sign Definitive License Agreement

Q BioMed Inc. (OTC Pink: QBIO), a biotechnology acceleration company is pleased to announce it has signed a definitive license, with the option to...


13 Oct, 2015, 08:00 ET Q BioMed Inc. Enters into Partnership with the Strategic and Scientific Advisory Firm Wombat Capital, Ltd.

     Q BioMed Inc (OTC: QBIO), a biotechnology acceleration and development company, has entered into a strategic relationship...